AstraZeneca seeks U.S. FDA approval for lung cancer treatment
Investing.com· Investing.com· Sep 29, 2026 · 1:25 AM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocksabout 1 hour ago
Wayfair sales jump 10% as furniture retailer says it's winning share of sluggish market
Wayfair said its sales jumped 10% in the third quarter as the retailer posted its strongest quarter since the pandemic.
CNBC Stocks
stocksabout 1 hour ago
Uber’s profit forecast disappoints as driver shortages, Middle East conflict hurt
Investing.com
stocksabout 1 hour ago
Why is Plug Power stock surging today?
Investing.com